My Best Biotech Stock for 2021
Here's why the biggest biotech IPO of 2019 outshines all its peers.
BridgeBio Pharma Inc
BBIO
BBIO
$65.13
-$2.28
-3.4%
Price as of February 25, 2021, 9:00 p.m. EST
View Interactive BBIO Charts
Interactive Chart
News & Analysis: BridgeBio Pharma Inc
3 Biotech Stocks That Could Double Your Money in 2021
Clinical trial readouts this year could cause these closely watched biotech stocks to explode overnight.
Got $5,000 and 5 Years to Wait? Buy This Under-the-Radar Biotech Stock Now
This company's about to begin delivering a stream of new drugs that target genetic diseases, and hardly anyone's heard about it.
2 Under-the-Radar Biotech Stocks You'll Wish You Didn't Ignore
These underappreciated biotechnology start-ups could turn heads one day -- but not yet.
BridgeBio Calls Off Its Acquisition Offer for Eidos Therapeutics
BridgeBio announced this week that it had terminated its effort to acquire the remaining stake in subsidiary Eidos Therapeutics. What does this mean for Eidos shareholders?
Are There Good Investments Among 2019's Biotech IPOs?
Investing in biotechs is inherently risky. IPOs are too. What does the stock performance of 2019’s biotech IPO class look like so far?
3 Top Biotech Stocks to Buy in October
These small-cap biotechs have fallen to bargain prices.
2 Small-Cap Biotechs With Huge Upside
These innovative healthcare companies promise investors a way to benefit from medical breakthroughs without the usual risk.
2 New Healthcare Stocks That Wall Street Thinks You Should Buy
This pair of healthcare businesses made their public debut in June, but they're already making a big impression.
